Search research articles
Contact Us
Filters
Showing results (51-60 of 195) with videos related to
Page
of 20
Sort By:
The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association
|
May 9, 2025
Risks of adverse health outcomes among older rural prostate cancer survivors in the SEER-Medicare data
Chun-Pin Chang Esther, Daren Huang, Shane Lloyd, et al.
Breast Cancer Research and Treatment
|
March 3, 2017
Identifying socio-demographic and clinical characteristics associated with medication beliefs about aromatase inhibitors among postmenopausal women with breast cancer
Teresa M Salgado, Emily J Davis, Karen B Farris, et al.
Breast Cancer Research and Treatment
|
November 19, 2024
Neighborhood socioeconomic deprivation and patient-reported outcomes in symptom management trials for women with breast cancer
Riha Vaidya, Cathee Till, N Lynn Henry, et al.
Breast Cancer Research and Treatment
|
June 27, 2022
Co-occurrence and metabolic biomarkers of sensory and motor subtypes of peripheral neuropathy from paclitaxel
Ciao-Sin Chen, Ellen M Lavoie Smith, Kathleen A Stringer, et al.
JCO Oncology Practice
|
September 19, 2022
Biomarkers for Systemic Therapy in Metastatic Breast Cancer: ASCO Guideline Update Q and A
Amy S Clark, Erin F Cobain, Zoneddy Dayao, et al.
JAMA Oncology
|
December 26, 2025
Baseline Fatigue and Severe Toxic Effects in Patients With Cancer Receiving Systemic Therapy
Joseph M Unger, Michael J Fisch, Salene M W Jones, et al.
Cancer Chemotherapy and Pharmacology
|
June 5, 2021
Feasibility of pharmacometabolomics to identify potential predictors of paclitaxel pharmacokinetic variability
Li Chen, Ciao-Sin Chen, Yihan Sun, et al.
JNCI Cancer Spectrum
|
December 13, 2021
Predictors of Pain Reduction in Trials of Interventions for Aromatase Inhibitor-Associated Musculoskeletal Symptoms
N Lynn Henry, Joseph M Unger, Cathee Till, et al.
Oncology
|
July 21, 2007
Phase II trial of copper depletion with tetrathiomolybdate as an antiangiogenesis strategy in patients with hormone-refractory prostate cancer
N Lynn Henry, Rodney Dunn, Sofia Merjaver, et al.
JCO Precision Oncology
|
January 31, 2025
Quantitation of Plasma Proteins to Predict Taxane-Induced Peripheral Neuropathy
Nam Nguyen-Hoang, Yaping Liu, N Lynn Henry, et al.
Page
of 20
Search research articles
Search
Showing results (51-60 of 195) with videos related to
Sort By:
Page
of 20
The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association
|
May 9, 2025
Risks of adverse health outcomes among older rural prostate cancer survivors in the SEER-Medicare data
Chun-Pin Chang Esther, Daren Huang, Shane Lloyd, et al.
Breast Cancer Research and Treatment
|
March 3, 2017
Identifying socio-demographic and clinical characteristics associated with medication beliefs about aromatase inhibitors among postmenopausal women with breast cancer
Teresa M Salgado, Emily J Davis, Karen B Farris, et al.
Breast Cancer Research and Treatment
|
November 19, 2024
Neighborhood socioeconomic deprivation and patient-reported outcomes in symptom management trials for women with breast cancer
Riha Vaidya, Cathee Till, N Lynn Henry, et al.
Breast Cancer Research and Treatment
|
June 27, 2022
Co-occurrence and metabolic biomarkers of sensory and motor subtypes of peripheral neuropathy from paclitaxel
Ciao-Sin Chen, Ellen M Lavoie Smith, Kathleen A Stringer, et al.
JCO Oncology Practice
|
September 19, 2022
Biomarkers for Systemic Therapy in Metastatic Breast Cancer: ASCO Guideline Update Q and A
Amy S Clark, Erin F Cobain, Zoneddy Dayao, et al.
JAMA Oncology
|
December 26, 2025
Baseline Fatigue and Severe Toxic Effects in Patients With Cancer Receiving Systemic Therapy
Joseph M Unger, Michael J Fisch, Salene M W Jones, et al.
Cancer Chemotherapy and Pharmacology
|
June 5, 2021
Feasibility of pharmacometabolomics to identify potential predictors of paclitaxel pharmacokinetic variability
Li Chen, Ciao-Sin Chen, Yihan Sun, et al.
JNCI Cancer Spectrum
|
December 13, 2021
Predictors of Pain Reduction in Trials of Interventions for Aromatase Inhibitor-Associated Musculoskeletal Symptoms
N Lynn Henry, Joseph M Unger, Cathee Till, et al.
Oncology
|
July 21, 2007
Phase II trial of copper depletion with tetrathiomolybdate as an antiangiogenesis strategy in patients with hormone-refractory prostate cancer
N Lynn Henry, Rodney Dunn, Sofia Merjaver, et al.
JCO Precision Oncology
|
January 31, 2025
Quantitation of Plasma Proteins to Predict Taxane-Induced Peripheral Neuropathy
Nam Nguyen-Hoang, Yaping Liu, N Lynn Henry, et al.
Page
of 20